Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but These are uncommon With this malignancy in comparison to other lymphoid neoplasms. CHD2 See "Qualified therapies in CLL: mechanisms of resistance and procedures for administration" on websit